Skip to main content
Internal Medicine logoLink to Internal Medicine
. 2023 May 31;63(2):323–326. doi: 10.2169/internalmedicine.1785-23

A Rare Case of Meningitis Caused by Streptococcus gallolyticus subsp. pasteurianus in an Immunocompetent Young Adult

Naoki Takegami 1,2, Shun-ichi Matsuda 1, Masaki Iizuka 1, Nanaka Yamaguchi-Takegami 1,2, Tatsushi Toda 2, Toshihiro Yoshizawa 1
PMCID: PMC10864060  PMID: 37258163

Abstract

Bacterial meningitis is a life-threatening condition that is mainly caused by Streptococcus pneumoniae and Neisseria meningitis. Although Streptococcus gallolyticus subsp. pasteurianus (Sgp) is also known to cause meningitis, its frequency is quite low, especially in adults. We herein report the first immunocompetent Japanese adult patient (20-year-old woman) with bacterial meningitis caused by Sgp. The patient showed dramatic improvement after antibiotic treatment. Although previous reports have described an association between Sgp infection and an immunosuppressive status, bowel and hepatobiliary diseases, or strongyloidiasis, our case did not demonstrate any of these conditions, suggesting that Sgp can cause meningitis even in young immunocompetent adults.

Keywords: bacterial meningitis, Streptococcus gallolyticus, Streptococcus gallolyticus subsp. pasteurianus, Streptococcus bovis

Introduction

Bacterial meningitis in adults is commonly caused by Streptococcus pneumoniae and Neisseria meningitidis (1). Other bacterial strains causing meningitis, such as Listeria monocytogenes and Staphylococcus aureus, are often associated with specific risk factors, including nosocomial, postoperative, or opportunistic infection (2). Escherichia coli and Klebsiella pneumoniae are both associated with meningitis in neonates and geriatric populations (1,2). Streptococcus gallolyticus subsp. pasteurianus (Sgp), formerly known as a member of Streptococcus bovis Biotype II/2, is a bacterium that has been reported to seldom cause meningitis (3).

We herein report a rare case of bacterial meningitis caused by Sgp in an immunocompetent adult.

Case Report

A 20-year-old woman presented to the emergency department with complaints of headache and vomiting without diarrhea for the past 2 days prior to hospital admission. Early in the morning on the day of admission, the patient was transferred to our hospital for emergency care due to further worsening of headache and vomiting and poor speech. She was afebrile upon admission (36.7°C), with stable vital signs. On a physical examination, the patient appeared agitated, had an altered consciousness [Glasgow Coma Scale (GCS): E3V4M5, Japan Coma Scale (JCS): 20], and had nuchal rigidity but no anisocoria. Auscultation revealed no heart murmur. An arterial blood gas analysis showed respiratory alkalosis with secondary metabolic acidosis (pH 7.51, PaCO2 23.9 mmHg, PaO2 103.1 mmHg, HCO3 18.9 mmol/L).

Computed tomography (CT) of the head did not reveal any acute abnormalities. She had no significant medical history. Laboratory workup showed leukocytosis with neutrophilic predominance [10,000 white blood cells (WBCs)/μL, 88.5% neutrophils], elevated C-reactive protein levels (1.37 mg/dL, normal range <0.30 mg/dL) and normal blood glucose (74 mg/dL, range 70-109 mg/dL) and ammonia levels (33 mg/dL, range 12-66 mg/dL).

As bacterial meningitis was suspected, lumbar puncture was performed. Purulent fluid was grossly identified. A cerebrospinal fluid (CSF) analysis revealed pleocytosis (WBC count of 4,736 cells/μL, with 92.0% segmented cells, 4.5% mononuclear cells, 3.0% lymphocytes), elevated total protein concentration (330 mg/dL), and low glucose concentration (5 mg/dL). CSF Gram staining was negative for organisms. The patient was admitted to the intensive care unit and started receiving high-dose meropenem (6 g/day), vancomycin (1,500 mg/day), and dexamethasone (7.5 mg/day).

The clinical condition of the patient improved considerably after 24 h of treatment (GCS: E4V5M6, JCS: 0). Her CSF cultures and two of the four bottles of blood cultures grew S. gallolyticus. Confirmation of bacterial identification was conducted by a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry technique and 16S rRNA sequencing, identifying Sgp. Magnetic resonance imaging of the brain showed no obvious abscess or aneurysm, and no cardiac lesions, including infective endocarditis, were found by a transthoracic echocardiogram. Based on the susceptibility of the bacteria, the antibacterial therapy was changed to ceftriaxone (4 g/day), and dexamethasone was discontinued. To search for a route of bacterial invasion, a dental evaluation was performed, but no active lesions considered to be a source of infection were observed. In addition, because S. gallolyticus infection is known to be associated with colorectal diseases, hepatobiliary disorders, and strongyloidiasis (4), we performed colonoscopy, abdominal ultrasound, a stool examination, and abdominal CT, all of which yielded negative results. None of these tests revealed any malformations, such as portosystemic shunt, that could be associated with bacteremia caused by enteric bacteria. There had been no recent changes in her bowel habit, no weight loss, no systemic symptoms - including skin rashes - prior to the onset of headache, and no unusual sexual activity. She was negative for human immunodeficiency virus, and her serum IgG level was near the lower limit of normal (791 mg/dL, range 800-1,700 mg/dL). The findings of a CSF analysis were normal after seven days of treatment.

The patient recovered quickly with complete resolution of symptoms after 14 days of antibiotic treatment. She was discharged on the 17th day of admission and followed up on an outpatient basis.

Discussion

S. gallolyticus is a Gram-positive coccus. Taxonomically, this strain is classified as S. bovis/S. equinus complex (SBSEC), a nonenterococcal group D Streptococcus spp. complex (5,6). S. gallolyticus was previously referred to as S. bovis Biotype II/2. Current phenotypic, proteomic, and molecular genetic techniques allow us to more precisely subdivisions of SBSEC, and the designation described below is now recommended (5). At present, this strain contains the following seven subspecies: S. gallolyticus subsp. gallolyticus (Sgg), S. gallolyticus subsp. macedonicus (Sgm), S. gallolyticus subsp. pasteurianus (Sgp), S. infantarius subsp. infantarius (Sii), S. lutetiensis, S. alactolyticus, and S. equinus (6).

S. gallolyticus accounts for 5-10% of the intestinal flora in normal adults (4). Previous studies have shown that S. gallolyticus infection is associated with a range of clinical presentations, including meningitis, bacteremia, infective endocarditis, colorectal cancer, chronic liver disease, and diabetes mellitus (7-11). There have been many publications concerning this strain; however, reports on subspecies other than Sgp and Sgg are scarce. Therefore, we summarize the clinical characteristics of Sgp and Sgg in Table.

Table.

Clinical Characteristics of Sgp and Sgg Infection.

Characteristics Sgg Sgp (this case)
Complications (12, 13)
Septic shock 13% 16%
Multiple organ failure 0% 2%
Thirty-day mortality 10% 17%
One-year motality 21% 58%
Coexisting condition (7-13)
Meningitis extremely rare elderly<infant, neonate
Infective endocarditis 43-100% 8-33%
Gastrointestinal disorders
Colorectal cancer 14-71% 0-22%
Pancreatic cancer 0% 17%
Chronic liver disease 14% 41-50%
Diabetes mellitus 0% 8-62.5%

Despite the similar clinical courses in the acute phase of Sgp or Sgg infection, a previous study showed that the prognosis at one year was poorer in Sgp infection than in Sgg infection (12,13). However, there is a possibility that coexisting malignancies may influence the prognosis. Although there is known to be a difference in the background factors of the infection between Sgp and Sgg, Sgp infection seems to be more closely associated with pancreatic cancer, chronic liver damage, diabetes mellitus, and meningitis. In contrast, the association of Sgp with infectious endocarditis and colorectal cancer seems to be weaker than that of Sgg infection (7-13). Strongyloidiasis is another coexisting condition in S. gallolyticus infection. There have been a few publications describing the association of S. gallolyticus meningitis with strongyloidiasis (14,15).

Previously, meningitis caused by S. bovis/SBSEC was reported as S. bovis meningitis, but recently, several papers described the subspecies of S. bovis/SBSEC (3,8-12). In a retrospective analysis of the Dutch cohort of adults with community-acquired meningitis (3), S. gallolyticus was very infrequently identified, being found in only 5 of 1,561 cases (0.3%). Among them, subspecies identification was performed in only one case, which was reported as Sgg. That study also reviewed publications concerning S. gallolyticus meningitis from 1975 to 2015. Eight of the nine cases in which subspecies identification was performed were reported to be caused by Sgp (3).

Furthermore, we extensively searched for papers concerning retrospective analyses summarizing S. gallolyticus infection and found five reports of cases coming from Japan (11), China (9), India (10), Denmark (12), and Spain (8). While S. gallolyticus causes a variety of disease conditions, meningitis caused by this strain was described in only one case report from China, in which the subspecies was Sgp (9). The above studies led us to believe that the frequency of S. gallolyticus meningitis in adults was quite low and that the majority of cases of S. gallolyticus meningitis were caused by Sgp.

Next, we searched the literature for pediatric cases of S. gallolyticus meningitis. We found more cases in children than in adults, especially in neonates and infants, which suggested that the frequency of S. gallolyticus meningitis in children might be higher than that observed in adults (16-18). According to the subspecies analysis, most of the cases were reported to be caused by Sgp. We found only one case of meningitis with S. lutetiensis infection (19). Interestingly, meningitis caused by Sgp has been reported even in animals (20,21). Although publication bias needs to be considered, Sgp seems to be the most meningitis-prone subspecies in SBSEC. In addition, neonates and infants may be more susceptible to Sgp than adults.

Based on information from the above literature search, we carefully collected the present patient's medical history and performed colonoscopy, abdominal ultrasound, a stool examination, and abdominal CT after remission was achieved. However, none of the conditions associated with Sgp infection, including strongyloidiasis, were identified. In addition, to identify bacterial migration and invasion routes from the intestinal tract to the CSF, we conducted dental examinations and searched for congenital malformations in the abovementioned imaging tests, but no abnormal findings were confirmed. In addition, based on the patient's medical history, we did not strongly suspect primary immunodeficiency; however, to search for latent immunodeficiency, an HIV test was performed and found to be negative. Serum IgG was around the lower limit of normal, but given the low albumin level, we considered it to be an effect of poor nutrition due to a decreased food intake for more than a few days and did not consider it to be due to an immunity problem. Since primary immunodeficiency was not strongly suspected based on our investigation, we decided to follow the patient on an outpatient basis instead of conducting a detailed evaluation of IgG subclass deficiency and leukocyte migration capacity in this hospitalization.

In conclusion, we herein report our experience with a rare adult case of bacterial meningitis caused by Sgp. Recently, the updated and revised taxonomy with available phenotypic, proteomic, and molecular genetic techniques has facilitated our understanding of the detailed associations between bacterial subspecies and meningitis. Being aware of the bacterial subspecies is important to clarify the accurate clinical picture of the infectious disease. There have been few reports on the association between Sgp and meningitis in immunocompetent adults, and further case studies are still anticipated in the future.

The authors state that they have no Conflict of Interest (COI).

Acknowledgement

The authors thank Dr. Xue Wu at the University of California San Francisco and Dr. Kristine Joyce Linay Porto at the University of Tokyo for proofreading the English manuscript.

References

  • 1. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351: 1849-1859, 2004. [DOI] [PubMed] [Google Scholar]
  • 2. Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 23: 467-492, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. van Samkar A, Brouwer MC, Pannekoek Y, van der Ende A, van de Beek D. Streptococcus gallolyticus meningitis in adults: report of five cases and review of the literature. Clin Microbiol Infect 21: 1077-1083, 2015. [DOI] [PubMed] [Google Scholar]
  • 4. Jans C, Boleij A. The road to infection: host-microbe interactions defining the pathogenicity of Streptococcus bovis/Streptococcus equinus complex members. Front Microbiol 9: 603, 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Jans C, Meile L, Lacroix C, Stevens MJ. Genomics, evolution, and molecular epidemiology of the Streptococcus bovis/Streptococcus equinus complex (SBSEC). Infect Genet Evol 33: 419-436, 2015. [DOI] [PubMed] [Google Scholar]
  • 6. Pompilio A, Di Bonaventura G, Gherardi G. An overview on Streptococcus bovis/Streptococcus equinus complex isolates: identification to the species/subspecies level and antibiotic resistance. Int J Mol Sci 20: 480, 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis 53: 870-878, 2011. [DOI] [PubMed] [Google Scholar]
  • 8. Romero B, Morosini MI, Loza E, et al. Reidentification of Streptococcus bovis isolates causing bacteremia according to the new taxonomy criteria: still an issue? J Clin Microbiol 49: 3228-3233, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Li Y, Chen X, Zhang Z, et al. Microbiological and clinical characteristics of Streptococcus gallolyticus subsp. pasteurianus infection in China. BMC Infect Dis 19: 791, 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Niyas VK, Arjun R, Sasidharan A, Palakunnath GA. Streptococcus gallolyticus bacteremia: an experience from a tertiary center in South India. Indian J Crit Care Med 24: 943-945, 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Kaiki Y, Kitagawa H, Tadera K, et al. Laboratory identification and clinical characteristics of Streptococcus bovis/Streptococcus equinus complex bacteremia: a retrospective, multicenter study in Hiroshima, Japan. BMC Infect Dis 21: 1192, 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Marmolin ES, Hartmeyer GN, Christensen JJ, et al. Bacteremia with the bovis group streptococci: species identification and association with infective endocarditis and with gastrointestinal disease. Diagn Microbiol Infect Dis 85: 239-242, 2016. [DOI] [PubMed] [Google Scholar]
  • 13. Sheng WH, Chuang YC, Teng LJ, Hsueh PR. Bacteraemia due to Streptococcus gallolyticus subspecies pasteurianus is associated with digestive tract malignancies and resistance to macrolides and clindamycin. J Infect 69: 145-153, 2014. [DOI] [PubMed] [Google Scholar]
  • 14. Shimasaki T, Chung H, Shiiki S. Five cases of recurrent meningitis associated with chronic strongyloidiasis. Am J Trop Med Hyg 92: 601-604, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Sasaki Y, Taniguchi T, Kinjo M, et al. Meningitis associated with strongyloidiasis in an area endemic for strongyloidiasis and human T-lymphotropic virus-1: a single-center experience in Japan between 1990 and 2010. Infection 41: 1189-1193, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Nguyen MT, Idriss S, Guzman E, De Oliveira ER. Neonatal meningitis, endocarditis, and pneumonitis due to Streptococcus gallolyticus subsp. pasteurianus: a case report. BMC Pediatr 19: 265, 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Williams C, Sakaria RP, Pourcyrous M. Early-onset fulminant sepsis in a preterm neonate due to Streptococcus gallolyticus: a case report and literature review. AJP Rep 12: e117-e122, 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Orbea M, Desai N, Foster C. Invasive Streptococcus gallolyticus infections in infants at Texas children's hospital: a 9-year retrospective review. Pediatr Infect Dis J 41: e494-e497, 2022. [DOI] [PubMed] [Google Scholar]
  • 19. Yu AT, Shapiro K, Beneri CA, Wilks-Gallo LS. Streptococcus lutetiensis neonatal meningitis with empyema. Access Microbiol 3: 000264, 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Trotta A, Sposato A, Marinaro M, et al. Neurological symptoms and mortality associated with Streptococcus gallolyticus subsp. pasteurianus in calves. Vet Microbiol 236: 108369, 2019. [DOI] [PubMed] [Google Scholar]
  • 21. Wang S, Ma M, Liang Z, et al. Pathogenic investigations of Streptococcus pasteurianus, an underreported zoonotic pathogen, isolated from a diseased piglet with meningitis. Transbound Emerg Dis 69: 2609-2620, 2022. [DOI] [PubMed] [Google Scholar]

Articles from Internal Medicine are provided here courtesy of Japanese Society of Internal Medicine

RESOURCES